Suda Kenichi 須田健一

… Alternative Names

SUDA Kenichi 須田健一

Less

Researcher Number	30631593
Other IDs
Affiliation (Current)	2025: 近畿大学, 医学部, 講師
Affiliation (based on the past Project Information) *help	2018 – 2024: 近畿大学, 医学部, 講師 2013 – 2015: 近畿大学, 医学部, 助教 2013: 九州大学, 大学病院, その他 2012: 九州大学, 大学病院, 臨床助教
Review Section/Research Field	Principal Investigator Basic Section 50020:Tumor diagnostics and therapeutics-related / Tumor therapeutics / Thoracic surgery Except Principal Investigator Basic Section 55040:Respiratory surgery-related / Medium-sized Section 55:Surgery of the organs maintaining homeostasis and related fields / Basic Section 50020:Tumor diagnostics and therapeutics-related
Keywords	Principal Investigator 獲得耐性 / 分子標的治療薬 / EGFR遺伝子変異 / 分子標的治療 / 肺癌 / 第4世代 / チロシンキナーゼ阻害剤 / EGFR変異肺がん / EGFR変異検査 / CD44 … More / 上皮間葉転換 / Drug tolerance / tumor heterogeneity / 肺腺がん / 免疫チェックポイント / 薬剤感受性 / バイオマーカー / heterogeniety / 個別化治療 / EGFR変異 / 耐性 / 分子標的薬 / 薬剤耐性 / 癌 … More Except Principal Investigator 肺がん / 薬剤耐性 / 肺癌 / 腫瘍微小環境 / マイクロバイオーム / 早期肺腺がん / 血小板 / 標的薬 / 変異 / KRAS / HER異常 / 胃がん / 乳がん / HER2異常 / ERBB2 / HER2 Less

Evaluation of minimal residual disease in postoperative lung cancer using platelet RNA influenced by the tumor environment.
- Principal Investigator
  
  坂井和子
- Project Period (FY)
  2024 – 2026
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 50020:Tumor diagnostics and therapeutics-related
- Research Institution
  Kindai University
Basic Research for Elucidating and Overcoming the Mechanisms of Progression of Early-Stage Lung Adenocarcinoma
- Principal Investigator
  
  宗淳一
- Project Period (FY)
  2023 – 2026
- Research Category
  
  Fund for the Promotion of Joint International Research (International Collaborative Research)
- Review Section
  
  Medium-sized Section 55:Surgery of the organs maintaining homeostasis and related fields
- Research Institution
  Kindai University
EGFR変異肺癌に対する第4世代EGFR-TKIの有用性とその獲得耐性機序の解明Principal Investigator
- Principal Investigator
  
  須田健一
- Project Period (FY)
  2022 – 2024
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 50020:Tumor diagnostics and therapeutics-related
- Research Institution
  Kindai University
Targeted therapy for the patient with KRAS mutant lung cancer
- Principal Investigator
  
  宗淳一
- Project Period (FY)
  2022 – 2024
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 55040:Respiratory surgery-related
- Research Institution
  Kindai University
Development of a new treatment strategy for HER2-alterated lung cancer
- Principal Investigator
  
  Soh Junichi
- Project Period (FY)
  2019 – 2021
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 55040:Respiratory surgery-related
- Research Institution
  Kindai University
Exploration of predictive molecular biomarkers for acquired resistance mechanisms to EGFR tyrosine kinase inhibitorsPrincipal Investigator
- Principal Investigator
  
  Suda Kenichi
- Project Period (FY)
  2018 – 2021
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 50020:Tumor diagnostics and therapeutics-related
- Research Institution
  Kindai University
肺癌における薬剤耐性因子のheterogenietyとその克服Principal Investigator
- Principal Investigator
  
  須田健一
- Project Period (FY)
  2015
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Tumor therapeutics
- Research Institution
  Kinki University
Analysis of acquired resistance mechanisms to next-generation kinase inhibitors in lung cancers with EGFR mutation.Principal Investigator
- Principal Investigator
  
  SUDA Kenichi
- Project Period (FY)
  2013 – 2014
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Tumor therapeutics
- Research Institution
  Kinki University
EGFR変異肺癌のキナーゼ阻害剤耐性機序の解明とその克服に向けた新規治療への展開Principal Investigator
- Principal Investigator
  
  須田健一
- Project Period (FY)
  2012 – 2013
- Research Category
  
  Grant-in-Aid for Research Activity Start-up
- Research Field
  
  Thoracic surgery
- Research Institution
  Kyushu University

All 2024 2023 2022 2021 2020 2019 2018 2015 2014 2013 2012 Other

All Journal Article Presentation Book

[Book] PTEN - Structure, Mechanisms-of-Action, Role in Cell Signaling and Regulation2013
- Author(s)
  Suda K, et al.
- Total Pages
  265
- Publisher
  NOVA BIOMEDICAL
- Data Source
  KAKENHI-PROJECT-25830119
[Journal Article] Secondary Mutations of the EGFR Gene That Confer Resistance to Mobocertinib in EGFR Exon 20 Insertion2024
- Author(s)
  Hamada Akira、Suda Kenichi、Nishino Masaya、Obata Keiko、Oiki Hana、Fukami Tomoyo、Fukuda Shota、Fujino Toshio、Ohara Shuta、Koga Takamasa、Chiba Masato、Shimoji Masaki、Ito Masaoki、Takemoto Toshiki、Soh Junichi、Tsutani Yasuhiro、Mitsudomi Tetsuya
- Journal Title
  
  Journal of Thoracic Oncology
  
  Volume: 19 Issue: 1 Pages: 71-79
- DOI
  10.1016/j.jtho.2023.08.029
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23K15569, KAKENHI-PROJECT-22K07291, KAKENHI-PROJECT-20K17763
[Journal Article] Recent Advances in Perioperative Immunotherapies in Lung Cancer2023
- Author(s)
  Fukuda S, Suda K, Hamada A, Tsutani Y.
- Journal Title
  
  Biomolecules
  
  Volume: 13 Issue: 9 Pages: 1377-1377
- DOI
  10.3390/biom13091377
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-22K07291
[Journal Article] Prognostic role of preoperative fluorine-18 fluorodeoxyglucose-positron emission tomography/computed tomography with an image-based harmonization technique: A multicenter retrospective study2023
- Author(s)
  Hamada A, Kitajima K, Suda K, Koga T, Soh J, Kaida H, Ito K, Sekine T, Takegahara K, Daisaki H, Hashimoto M, Yoshida Y, Kabasawa T, Yamasaki T, Hirota S, Usuda J, Ishii K, Mitsudomi T.
- Journal Title
  
  JTCVS Open
  
  Volume: 14 Pages: 502-22
- DOI
  10.1016/j.xjon.2023.02.004
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-22K07291, KAKENHI-PROJECT-20K17763
[Journal Article] Performance of Ultra-Rapid Idylla EGFR Mutation Test in Non-Small-Cell Lung Cancer and Its Potential at Clinical Molecular Screening2023
- Author(s)
  Suda K, Sakai K, Ohira T, Chikugo T, Satou T, Matsubayashi J, Nagao T, Ikeda N, Tsutani Y, Mitsudomi T, Nishio K.
- Journal Title
  
  Cancers
  
  Volume: 15 Issue: 9 Pages: 2648-2648
- DOI
  10.3390/cancers15092648
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-22K07291, KAKENHI-PROJECT-23K06432
[Journal Article] Utility of the Ba/F3 cell system for exploring on-target mechanisms of resistance to targeted therapies for lung cancer.2022
- Author(s)
  Koga T, Suda K, Mitsudomi T.
- Journal Title
  
  Cancer Science
  
  Volume: 113 Issue: 3 Pages: 815-827
- DOI
  10.1111/cas.15263
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-18K07336
[Journal Article] Frequent EGFR Mutations and Better Prognosis in Positron Emission Tomography-Negative, Solid-Type Lung Cancer.2022
- Author(s)
  Suda K, Ohara S, Fujino T, Hamada A, M Chiba, Shimoji M, Takemoto T, Soh J, Mitsudomi T.
- Journal Title
  
  Clinical Lung Cancer
  
  Volume: 23 Issue: 1 Pages: e60-e68
- DOI
  10.1016/j.cllc.2021.10.003
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-18K07336
[Journal Article] 肺癌の分子標的治療の現状と展望.2022
- Author(s)
  須田健一, 光冨徹哉.
- Journal Title
  
  胸部外科
  
  Volume: 75 Pages: 53-66
- NAID
  40022786239
- Data Source
  KAKENHI-PROJECT-18K07336
[Journal Article] Cell Line Models for Acquired Resistance to First-Line Osimertinib in Lung Cancers-Applications and Limitations2021
- Author(s)
  Ohara S, Suda K, Mitsudomi T
- Journal Title
  
  Cells
  
  Volume: 10 Issue: 2 Pages: 354-354
- DOI
  10.3390/cells10020354
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-18K07336, KAKENHI-PROJECT-20K17764
[Journal Article] Lung Cancer with MET exon 14 Skipping Mutation: Genetic Feature, Current Treatments, and Future Challenges.2021
- Author(s)
  Fujino T, Suda K, Mitsudomi T.
- Journal Title
  
  Lung Cancer: Targets and Therapy
  
  Volume: 12 Pages: 35-50
- DOI
  10.2147/lctt.s269307
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-18K07336, KAKENHI-PROJECT-19K16813, KAKENHI-PROJECT-21K15580
[Journal Article] KRAS Secondary Mutations That Confer Acquired Resistance to KRAS G12C Inhibitors, Sotorasib and Adagrasib, and Overcoming Strategies: Insights From In_Vitro Experiments.2021
- Author(s)
  Koga T, Suda K, Fujino T, Ohara S, Hamada A, Nishino M, Chiba M, Shimoji M, Takemoto T, Arita R, Gmachl M, Hofmann MH, Soh J, Mitsudomi T.
- Journal Title
  
  Journal of Thoracic Oncology
  
  Volume: 16 Issue: 8 Pages: 1321-1332
- DOI
  10.1016/j.jtho.2021.04.015
- Peer Reviewed / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-18K07336
[Journal Article] Drug Tolerance to EGFR Tyrosine Kinase Inhibitors in Lung Cancers with EGFR Mutations.2021
- Author(s)
  Suda K, Mitsudomi T.
- Journal Title
  
  Cells
  
  Volume: 10 Issue: 7 Pages: 1590-1590
- DOI
  10.3390/cells10071590
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-18K07336
[Journal Article] Activity and mechanism of acquired resistance to tarloxotinib in HER2 mutant lung cancer: an in vitro study.2021
- Author(s)
  Koga T, Suda K, Nishino M, Fujino T, Ohara S, Hamada A, Soh J, Tirunagaru V, Vellanki A, Doebele RC, Mitsudomi T.
- Journal Title
  
  Translational Lung Cancer Research
  
  Volume: 10 Issue: 8 Pages: 3659-3670
- DOI
  10.21037/tlcr-21-216
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-18K07336, KAKENHI-PROJECT-19K09285
[Journal Article] In vitro validation study of HER2 and HER4 mutations identified in an ad hoc secondary analysis of the LUX-Lung 8 randomized clinical trial.2021
- Author(s)
  Hamada A, Suda K, Koga T, Fujino T, Nishino M, Ohara S, Chiba M, Shimoji M, Takemoto T, Soh J, Uchida T, Mitsudomi T.
- Journal Title
  
  Lung Cancer
  
  Volume: 162 Pages: 79-85
- DOI
  10.1016/j.lungcan.2021.10.014
- Peer Reviewed / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-18K07336, KAKENHI-PROJECT-19K09285, KAKENHI-PROJECT-20K17763
[Journal Article] Inter- and Intratumor Heterogeneity of EGFR Compound Mutations in Non-Small Cell Lung Cancers: Analysis of Five Cases2021
- Author(s)
  Suda K, Sakai K, Obata K, Ohara S, Fujino T, Koga T, Hamada A, Soh J, Nishio K, Mitsudomi T
- Journal Title
  
  Clinical Lung Cancer
  
  Volume: 22 Issue: 2 Pages: e141-e145
- DOI
  10.1016/j.cllc.2020.09.009
- Peer Reviewed / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-18K07336
[Journal Article] Dose-dependence in acquisition of drug tolerant phenotype and high RYK expression as a mechanism of osimertinib tolerance in lung cancer2021
- Author(s)
  Ohara S, Suda K, Fujino T, Hamada A, Koga T, Nishino M, Chiba M, Shimoji M, Takemoto T, Soh J, Mitsudomi T
- Journal Title
  
  Lung Cancer
  
  Volume: 154 Pages: 84-91
- DOI
  10.1016/j.lungcan.2021.02.017
- Peer Reviewed / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-18K07336, KAKENHI-PROJECT-19K16785, KAKENHI-PROJECT-20K17764
[Journal Article] Recent Advances in Cancer Immunotherapy.2021
- Author(s)
  Suda K.
- Journal Title
  
  Biomolecules
  
  Volume: 11 Issue: 2 Pages: 335-335
- DOI
  10.3390/biom11020335
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-18K07336
[Journal Article] 早期肺がんへのLiquid biopsyの応用 -再発予測としてのMinimal Residual Disease検出の意義-.2021
- Author(s)
  小原秀太, 須田健一, 光冨徹哉.
- Journal Title
  
  近畿大学医学雑誌
  
  Volume: 46 Pages: 73-78
- Data Source
  KAKENHI-PROJECT-18K07336
[Journal Article] Prognostic value of plasma fibrinogen and D-dimer levels in patients with surgically resected non-small cell lung cancer2020
- Author(s)
  Ohara S, Suda K, Tomizawa K, Takemoto T, Fujino T, Hamada A, Koga T, Nishino M, Chiba M, Sato K, Shimoji M, Soh J, Mitsudomi T
- Journal Title
  
  Surgery Today
  
  Volume: 50 Issue: 11 Pages: 1427-1433
- DOI
  10.1007/s00595-020-02019-1
- Peer Reviewed / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-18K07336, KAKENHI-PROJECT-20K17764
[Journal Article] Spatial heterogeneity of acquired resistance mechanisms to 1st/2nd generation EGFR tyrosine kinase inhibitors in lung cancer2020
- Author(s)
  Suda K, Murakami I, Obata K, Sakai K, Fujino T, Koga T, Ohara S, Hamada A, Soh J, Nishio K, Mitsudomi T
- Journal Title
  
  Lung Cancer
  
  Volume: 148 Pages: 100-104
- DOI
  10.1016/j.lungcan.2020.08.010
- Peer Reviewed / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-18K07336
[Journal Article] Emerging oncogenic fusions other than ALK, ROS1, RET, and NTRK in NSCLC and the role of fusions as resistance mechanisms to targeted therapy2020
- Author(s)
  Suda K, Mitsudomi T
- Journal Title
  
  Translational Lung Cancer Research
  
  Volume: 9 Issue: 6 Pages: 2618-2628
- DOI
  10.21037/tlcr-20-186
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-18K07336
[Journal Article] Emerging MET tyrosine kinase inhibitors for the treatment of non-small cell lung cancer2020
- Author(s)
  Fujino T, Suda K, Mitsudomi T
- Journal Title
  
  Expert Opinion on Emerging Drugs
  
  Volume: 25 Issue: 3 Pages: 229-249
- DOI
  10.1080/14728214.2020.1791821
- Peer Reviewed / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-18K07336, KAKENHI-PROJECT-19K16813
[Journal Article] Comparison of PD-L1 Expression Status Between Pure-Solid Versus Part-Solid Lung Adenocarcinomas.2019
- Author(s)
  Suda K, Shimoji M, Shimizu S, Sato K, Chiba M, Tomizawa K, Takemoto T, Soh J, Mitsudomi T.
- Journal Title
  
  Biomolecules
  
  Volume: 9 Issue: 9 Pages: 456-456
- DOI
  10.3390/biom9090456
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-18K07336
[Journal Article] The ABCs of Preventing Hyperprogressive Disease After Immunotherapy: Awareness, Biomarkers, and Combination.2019
- Author(s)
  Suda K.
- Journal Title
  
  Journal of Thoracic Disease
  
  Volume: 11 (Suppl 3) Issue: S3 Pages: S347-S351
- DOI
  10.21037/jtd.2018.12.112
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-18K07336
[Journal Article] For a better adjuvant strategy for resected lung cancer-lessons from treatment failure patterns of the ADJUVANT trial (CTONG 1104).2019
- Author(s)
  Suda K.
- Journal Title
  
  Translational Lung Cancer Research
  
  Volume: 8 (Suppl 4) Issue: S4 Pages: S395-S399
- DOI
  10.21037/tlcr.2019.08.24
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-18K07336
[Journal Article] Sensitivity and Resistance of MET Exon 14 Mutations in Lung Cancer to Eight MET Tyrosine Kinase Inhibitors In Vitro2019
- Author(s)
  Fujino T, Kobayashi Y, Suda K, Koga T, Nishino M, Ohara S, Chiba M, Shimoji M, Tomizawa K, Takemoto T, Mitsudomi T.
- Journal Title
  
  Journal of Thoracic Oncology
  
  Volume: 14 Issue: 10 Pages: 1753-1765
- DOI
  10.1016/j.jtho.2019.06.023
- Peer Reviewed / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-18K07336, KAKENHI-PROJECT-16H06276
[Journal Article] Effects of secondary EGFR mutations on resistance against upfront osimertinib in cells with EGFR-activating mutations in vitro.2018
- Author(s)
  Nishino M, Suda K, Kobayashi Y, Ohara S, Fujino T, Koga T, Chiba M, Shimoji M, Tomizawa K, Takemoto T, Mitsudomi T
- Journal Title
  
  Lung Cancer
  
  Volume: 126 Pages: 149-155
- DOI
  10.1016/j.lungcan.2018.10.026
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-18K07336
[Journal Article] CD44 Facilitates Epithelial-to-Mesenchymal Transition Phenotypic Change at Acquisition of Resistance to EGFR Kinase Inhibitors in Lung Cancer.2018
- Author(s)
  Suda K, Murakami I, Yu H, Kim J, Tan AC, Mizuuchi H, Rozeboom L, Ellison K, Rivard CJ, Mitsudomi T, Hirsch FR
- Journal Title
  
  Molecular Cancer Therapeutics
  
  Volume: 10 Pages: 2257-2265
- Peer Reviewed / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-18K07336
[Journal Article] Innate Genetic Evolution of Lung Cancers and Spatial Heterogeneity: Analysis of Treatment-Naive Lesions.2018
- Author(s)
  Suda K, Kim J, Murakami I, Rozeboom L, Shimoji M, Shimizu S, Rivard CJ, Mitsudomi T, Tan AC, Hirsch FR
- Journal Title
  
  Journal of Thoracic Oncology
  
  Volume: 10 Issue: 10 Pages: 1496-1507
- DOI
  10.1016/j.jtho.2018.05.039
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-18K07336
[Journal Article] Intraoperative molecular imaging-a bright navigator for thoracic surgeons in the era of limited resection.2018
- Author(s)
  Suda K
- Journal Title
  
  Translational Lung Cancer Research
  
  Volume: Suppl 3. Issue: S3 Pages: S232-S235
- DOI
  10.21037/tlcr.2018.08.13
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-18K07336
[Journal Article] Racial differences in lung cancer genetics.2015
- Author(s)
  Kenichi Suda, and Tetsuya Mitsudomi
- Journal Title
  
  Journal of Thoracic Oncology
  
  Volume: 10 Issue: 2 Pages: 230-1
- DOI
  10.1097/jto.0000000000000439
- Acknowledgement Compliant
- Data Source
  KAKENHI-PROJECT-25830119
[Journal Article] Role of EGFR mutations in lung cancers: prognosis and tumor chemosensitivity2015
- Author(s)
  Suda K., Mitsudomi T.
- Journal Title
  
  Arch Toxicol
  
  Volume: 89 Issue: 8 Pages: 1227-40
- DOI
  10.1007/s00204-015-1524-7
- Peer Reviewed / Acknowledgement Compliant
- Data Source
  KAKENHI-PROJECT-15K18450
[Journal Article] Recent evidence, advances, and current practices in surgical treatment of lung cancer2014
- Author(s)
  Kenichi Suda, Katsuaki Sato, Hiroshi Mizuuchi, Yoshihisa Kobayashi, Masaki Shimoji, Kenji Tomizawa, Toshiki Takemoto, Takuya Iwasaki, Masahiro Sakaguchi, Tetsuya Mitsudomi
- Journal Title
  
  Respiratory Investigation
  
  Volume: 52 Issue: 6 Pages: 322-9
- DOI
  10.1016/j.resinv.2014.06.003
- Peer Reviewed / Acknowledgement Compliant
- Data Source
  KAKENHI-PROJECT-25830119
[Journal Article] CRKL amplification is rare as a mechanism for acquired resistance tokinase inhibitors in lung cancers with epidermal growth factorreceptor mutation2014
- Author(s)
  Kenichi Suda, Hiroshi Mizuuchi, Isao Murakami, Hidetaka Uramoto,Fumihiro Tanaka, Katsuaki Sato, Toshiki Takemoto, Takuya Iwasaki,Yoshitaka Sekido, Yasushi Yatabe, Tetsuya Mitsudomi
- Journal Title
  
  Lung Cancer
  
  Volume: 85 Pages: 147-51
- Peer Reviewed / Acknowledgement Compliant
- Data Source
  KAKENHI-PROJECT-25830119
[Journal Article] Prognostic Implication of Predominant Histologic Subtypes of Lymph Node Metastases in Surgically Resected Lung Adenocarcinoma2014
- Author(s)
  Kenichi Suda, Katsuaki Sato, Shigeki Shimizu, Kenji Tomizawa, Toshiki Takemoto, Takuya Iwasaki, Masahiro Sakaguchi, and Tetsuya Mitsudomi
- Journal Title
  
  BioMed Research International
  
  Volume: 2014 Pages: 1-6
- DOI
  10.1155/2014/645681
- Peer Reviewed / Acknowledgement Compliant / Open Access
- Data Source
  KAKENHI-PROJECT-25830119
[Journal Article] The insulin-like growth factor 1 receptor causes acquired resistance to erlotinib in lung cancer cells with the wild-type epidermal growth factor receptor.2014
- Author(s)
  Suda K, Mizuuchi H, Sato K, Takemoto T, Iwasaki T, Mitsudomi T.
- Journal Title
  
  Int. J. Cancer
  
  Volume: in press Issue: 4 Pages: 1002-6
- DOI
  10.1002/ijc.28737
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-25830119
[Journal Article] Unintentional Weakness of Cancers: The MEK–ERK Pathway as a Double-Edged Sword.2013
- Author(s)
  Suda K and Mitsudomi T.
- Journal Title
  
  Molecular Cancer Research
  
  Volume: 11 Issue: 10 Pages: 1125-8
- DOI
  10.1158/1541-7786.mcr-13-0228
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-25830119
[Journal Article] Development of personalized treatments in lung cancer: focusing on the EGFR mutations and beyond.2013
- Author(s)
  Suda K and Mitsudomi T.
- Journal Title
  
  Lung Cancer: Targets and THerapy
  
  Volume: 4 Pages: 43-53
- DOI
  10.2147/lctt.s49603
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-25830119
[Journal Article] 肺癌UPDATE 肺癌の分子生物学　肺癌のoncogenic driver mutations2012
- Author(s)
  須田　健一、　他
- Journal Title
  
  医学のあゆみ
  
  Volume: 240 Pages: 1059-65
- Data Source
  KAKENHI-PROJECT-24890159
[Journal Article] EGFR tyrosine kinase inhibitors prolong overall survival in EGFR mutated non-small-cell lung cancer patients with postsurgical recurrence2012
- Author(s)
  Suda K., et al.
- Journal Title
  
  Journal of Cancer Research Updates
  
  Volume: 1 Pages: 102-7
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-24890159
[Journal Article] 抗がん剤治療の最前線：分子標的薬剤の使用による進歩（後篇）2012
- Author(s)
  須田　健一、　他
- Journal Title
  
  最新医学
  
  Volume: 67 Pages: 2104-15
- Data Source
  KAKENHI-PROJECT-24890159
[Journal Article] Genetic and Prognostic Differences of Non-small Cell Lung Cancer between Elderly Patients and Younger Counterparts.2012
- Author(s)
  Suda K., et al.
- Journal Title
  
  Aging and Disease
  
  Volume: 6 Pages: 438-43
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-24890159
[Journal Article] Conversion from the "oncogene addiction" to "drug addiction" by intensive inhibition of the EGFR and MET in lung cancer with activating EGFR mutation.2012
- Author(s)
  Suda K, et al.
- Journal Title
  
  Lung Cancer.
  
  Volume: 76 Issue: 3 Pages: 292-299
- DOI
  10.1016/j.lungcan.2011.11.007
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23501281, KAKENHI-PROJECT-24890159
[Journal Article] Acquired resistance mechanisms to tyrosine kinase inhibitors in lung cancer with activating epidermal growth factor receptor mutation--diversity, ductility, and destiny.2012
- Author(s)
  Suda K., et al.
- Journal Title
  
  Cancer and Metastasis Reviews
  
  Volume: 3-4 Issue: 3-4 Pages: 807-14
- DOI
  10.1007/s10555-012-9391-7
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-24890159
[Presentation] Minimal Residual Disease2023
- Author(s)
  須田健一，小原秀太，宗淳一，津谷康大，光冨徹哉
- Organizer
  第61回日本癌治療学会
- Invited
- Data Source
  KAKENHI-PROJECT-22K07291
[Presentation] Best of WCLC: Early disease: Surgery/Perioperative treatments2023
- Author(s)
  須田健一
- Organizer
  第64回日本肺癌学会学術集会
- Invited
- Data Source
  KAKENHI-PROJECT-22K07291
[Presentation] 肺がん術後補助療法変革元年における当院での実施状況の変遷2023
- Author(s)
  須田健一,　小原秀太,　千葉眞人,　下治正樹,　武本智樹,　宗淳一,　津谷康大
- Organizer
  第66回関西胸部外科学会学術集会
- Data Source
  KAKENHI-PROJECT-22K07291
[Presentation] 肺がん周術期がん免疫治療の現状とバイオマーカー2023
- Author(s)
  須田健一、小原秀太、濱田顕、千葉眞人、伊藤正興、下治正樹、武本智樹、宗淳一、光冨徹哉、津谷康大
- Organizer
  第74回日本気管食道科学会総会
- Invited
- Data Source
  KAKENHI-PROJECT-22K07291
[Presentation] 肺がん外科領域におけるがん免疫療法の進歩と呼吸器外科医の役割2023
- Author(s)
  須田健一、濵田顕、宗淳一、小原秀太、千葉眞人、武本智樹、光冨徹哉、津谷康大
- Organizer
  第123回日本外科学会定期学術集会
- Data Source
  KAKENHI-PROJECT-22K07291
[Presentation] Discussant: #584 GENETIC PROFILES AND IMMUNE CHECKPOINT EXPRESSION OF PRIMARY OLIGOMETASTATIC NON-SMALL CELL LUNG CANCER AND CORRESPONDING BRAIN METASTASES2023
- Author(s)
  Kenichi Suda
- Organizer
  31st ESTS Meeting
- Invited / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-22K07291
[Presentation] N0/1 Staging for Limited Resection and Resectable N2 NSCLC2023
- Author(s)
  Kenichi Suda
- Organizer
  WCLC 2023
- Invited / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-22K07291
[Presentation] PD-L1 高発現 EGFR 変異肺がん外科切除例の検討―術後補助療法の観点から考える―2023
- Author(s)
  須田健一、老木華、福田祥大、深見朋世、小原秀太、濵田顕、伊藤正興、千葉眞人、下治正樹、武本智樹、宗淳一、光冨徹哉、津谷康大
- Organizer
  第64回日本肺癌学会学術集会
- Data Source
  KAKENHI-PROJECT-22K07291
[Presentation] EGFR 変異肺がん外科切除例の病態解明と TKI 耐性克服を目指したトランスレーショナル研究2023
- Author(s)
  須田健一
- Organizer
  第40回日本呼吸器外科学会学術集会
- Invited
- Data Source
  KAKENHI-PROJECT-22K07291
[Presentation] In vitro activity and potential resistance mutations against BI-4020, a 4th generation EGFR-TKI2022
- Author(s)
  Kenichi Suda, Toshio Fujino, Akira Hamada, Shuta Ohara, Junichi Soh, Tetsuya Mitsudomi
- Organizer
  2022 World Conference on Lung Cancer
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-22K07291
[Presentation] 肺がんを知る―飽くなき探求心を引き継いで2022
- Author(s)
  須田健一
- Organizer
  第 63 回日本肺癌学会学術集会
- Invited
- Data Source
  KAKENHI-PROJECT-22K07291
[Presentation] 肺がん分子標的治療薬に対する on-target の獲得耐性機序の同定とその克服2022
- Author(s)
  須田健一、古賀教将、西野将矢、藤野智大、濵田顕、下治正樹、千葉眞人、武本智樹、宗淳一、光冨徹哉
- Organizer
  第 122 回日本外科学会定期学術集会
- Data Source
  KAKENHI-PROJECT-22K07291
[Presentation] Correlation of SUVmax of primary lung tumor and occult lymph node metastases in clinical stage I lung adenocarcinoma2022
- Author(s)
  Kenichi Suda, Shota Fukuda, Shuta Ohara, Akira Hamada, Masato Chiba, Masaki Shimoji, Toshiki Takemoto, Junichi Soh, Yasuhiro Tsutani, Tetsuya Mitsudomi
- Organizer
  IASLC 2022 Asia Conference on Lung Cancer
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-22K07291
[Presentation] TKI耐性2次的変異を同定する手法としてのBa/F3細胞モデルの有用性2021
- Author(s)
  須田健一，古賀教将，藤野智大，濵田顕，宗淳一，光冨徹哉
- Organizer
  第115回日本肺癌学会関西支部学術集会
- Data Source
  KAKENHI-PROJECT-18K07336
[Presentation] Inter-tumor heterogeneity of CD44 expression in non-small cell lung cancers / EGFR-mutated lung adenocarcinomas2021
- Author(s)
  Suda K, Rivard CJ, Yu H, Fujino T, Koga T, Soh J, Hirsch FR, Mitsudomi T.
- Organizer
  2021 World Conference on Lung Cancer
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-18K07336
[Presentation] 病理病期 IA2-IIA 期 EGFR 変異肺がんに対するUFT術後補助療法の有用性2021
- Author(s)
  須田健一、濱田顕、小原秀太、藤野智大、古賀教将、西野将矢、千葉眞人、下治正樹、武本智樹、宗淳一、光冨徹哉
- Organizer
  第62回日本肺癌学会学術集会
- Data Source
  KAKENHI-PROJECT-18K07336
[Presentation] EGFR 肺がん外科切除例の特徴と予後－周術期分子標的治療を視野に入れて2021
- Author(s)
  須田健一、光冨徹哉
- Organizer
  第62回日本肺癌学会学術集会
- Invited
- Data Source
  KAKENHI-PROJECT-18K07336
[Presentation] 「pN 陽性」非小細胞肺がんにおけるすりガラス成分の有無の予後因子としての意義2021
- Author(s)
  須田健一、小原秀太、西野将矢、古賀教将、藤野智大、濱田顕、千葉眞人、武本智樹、宗淳一、光冨徹哉
- Organizer
  第38回日本呼吸器外科学会学術集会
- Data Source
  KAKENHI-PROJECT-18K07336
[Presentation] EGFR変異肺がんにおけるEGFRチロシンキナーゼ阻害剤耐性克服を目指したトランスレーショナルリサーチ2020
- Author(s)
  須田健一、光冨徹哉
- Organizer
  第79回日本癌学会学術総会
- Invited
- Data Source
  KAKENHI-PROJECT-18K07336
[Presentation] In Vitro Validation Study for HER2 Mutations in Squamous Cell Carcinoma as a Potential Predictive Factor Identified in Secondary Analysis of the LUX-Lung 8 Trial2020
- Author(s)
  Akira Hamada, Kenichi Suda, Toshio Fujino, Masaya Nishino, Takamasa Koga, Shuta Ohara, Masato Chiba, Toshiki Takemoto, Junichi Soh, Tetsuya Mitsudomi
- Organizer
  2020 World Conference on Lung Cancer
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-19K09285
[Presentation] 第1/2世代 EGFR キナーゼ阻害剤に対する獲得耐性機序の inter-tumor heterogeneity とその臨床的意義2020
- Author(s)
  須田健一、村上功、小畑慶子、藤野智大、坂井和子、宗淳一、西尾和人、光冨徹哉
- Organizer
  第79回日本癌学会学術総会
- Data Source
  KAKENHI-PROJECT-18K07336
[Presentation] Inter- and intra-tumor heterogeneity of EGFR compound mutations in lung adenocarcinoma2020
- Author(s)
  Suda K, Sakai K, Obata K, Ohara S, Fujino T, Koga T, Hamada A, Soh J, Nishio K, Mitsudomi T
- Organizer
  第61回日本肺癌学会学術集会
- Data Source
  KAKENHI-PROJECT-18K07336
[Presentation] In Vitro Validation Study for Afatinib Efficacy in Lung Squamous Cell Carcinoma with HER2 Mutations Identified in LUX-Lung 8 Trial2020
- Author(s)
  Akira Hamada, Kenichi Suda, Toshio Fujino Shuta Ohara, Junichi Soh, Tetsuya Mitsudomi
- Organizer
  第79回日本癌学会総会
- Data Source
  KAKENHI-PROJECT-19K09285
[Presentation] 掻把術にて根治できなかった難治性術後膿胸に対するクリスタルバイオレットを用いた胸腔内洗浄の有用性2020
- Author(s)
  須田健一、小原秀太、西野将矢、古賀教将、藤野智大、濱田顕、千葉眞人、武本智樹、宗淳一、光冨徹哉
- Organizer
  第37回日本呼吸器外科学会学術集会
- Data Source
  KAKENHI-PROJECT-18K07336
[Presentation] Pure solid を呈するもPET 陰性であった原発性肺癌の臨床病理学的特徴2020
- Author(s)
  須田健一、小原秀太、西野将矢、藤野智大、古賀教将、濱田顕、千葉眞人、武本智樹、宗淳一、光冨徹哉
- Organizer
  第120回日本外科学会定期学術集会
- Data Source
  KAKENHI-PROJECT-18K07336
[Presentation] Potent in vitro activity of Tarloxotinib for EGFR C797S and other mutations refractory to current EGFR tyrosine kinase inhibitors2019
- Author(s)
  Suda K, Nishino M, Koga T, Fujino T, Kobayashi Y, Mitsudomi T, Vellanki A, Tirunagaru V.
- Organizer
  AACR Annual Meeting 2019
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-18K07336
[Presentation] pStage IA NSCLCs with ground-glass opacity: are their candidates for Tegafur/Uracil adjuvant chemotherapy?2019
- Author(s)
  Suda K, Ohara S, Koga T, Fujino T, Hamada A, Nishino M, Chiba M, Takemoto T, Soh J, Mitsudomi T.
- Organizer
  第60回日本肺癌学会学術集会
- Data Source
  KAKENHI-PROJECT-18K07336
[Presentation] CD44 Facilitates Epithelial-to-Mesenchymal Transition Phenotypic Change at Acquisition of Resistance to EGFR Kinase Inhibitors in Lung Cancer.2019
- Author(s)
  須田健一
- Organizer
  第119回日本外科学会定期学術集会
- Invited
- Data Source
  KAKENHI-PROJECT-18K07336
[Presentation] IASLC5: The importance of IASLC Membership for career development opportunities: My personal experience.2019
- Author(s)
  Suda K.
- Organizer
  第60回日本肺癌学会学術集会
- Invited
- Data Source
  KAKENHI-PROJECT-18K07336
[Presentation] Comparison of PD-L1 expression status between pure-solid versus part-solid tumors in lung adenocarcinomas.2019
- Author(s)
  Suda K, Shimizu S, Shimoji M, Sato K, Ohara S, Fujino T, Nishino M, Koga T, Hamada A, Tomizawa K, Takemoto T, Soh J, Mitsudomi T.
- Organizer
  2019 World Conference on Lung Cancer
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-18K07336
[Presentation] 肺腺がんにおけるPD-L1発現ーすりガラス陰影の有無との関連2019
- Author(s)
  須田健一、下治正樹、西野将矢、藤野智大、古賀教将、小原秀太、千葉眞人、武本智樹、清水重喜、光冨徹哉
- Organizer
  第119回日本外科学会定期学術集会
- Data Source
  KAKENHI-PROJECT-18K07336
[Presentation] T790M or C797S confers acquired resistance to tarloxotinib and poziotinibin EGFR exon 20 insertion-driven lung cancer models in vitro.2019
- Author(s)
  Suda K, Nishino M, Koga T, Fujino T, Ohara S, Soh J, Vellanki A, Tirunagaru V, Mitsudomi T.
- Organizer
  2019 World Conference on Lung Cancer
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-18K07336
[Presentation] 自己免疫疾患を有する非小細胞肺癌切除例の短期成績と長期予後2019
- Author(s)
  須田健一、小原秀太、西野将矢、千葉眞人、武本智樹、宗淳一、光冨徹哉
- Organizer
  第72回日本胸部外科学会定期学術集会
- Data Source
  KAKENHI-PROJECT-18K07336
[Presentation] 腸型肺腺がんの3切除例2019
- Author(s)
  須田健一、清水重喜、小原秀太、西野将矢、藤野智大、古賀教将、千葉眞人、下治正樹、武本智樹、光冨徹哉
- Organizer
  第109回日本肺癌学会関西支部会
- Data Source
  KAKENHI-PROJECT-18K07336
[Presentation] Prediction and prevention of acquired resistance to EGFR-TKIs: a story of HCC4006 cells2018
- Author(s)
  Kenichi Suda and Tetsuya Mitsudomi
- Organizer
  第59回日本肺癌学会総会
- Invited
- Data Source
  KAKENHI-PROJECT-18K07336
[Presentation] EGFR-TKI 獲得耐性に伴う上皮間葉転換（EMT）におけるCD44 の役割2018
- Author(s)
  須田健一、村上功、JihyeKim、Christopher J. Rivard、光冨徹哉、Fred R. Hirsch
- Organizer
  第118回日本外科学会定期学術集会
- Data Source
  KAKENHI-PROJECT-18K07336
[Presentation] EGFR キナーゼ阻害剤獲得耐性における分子異常の heterogeneity の検討とその克服2018
- Author(s)
  須田健一
- Organizer
  第118回日本外科学会定期学術集会
- Invited
- Data Source
  KAKENHI-PROJECT-18K07336
[Presentation] 早期非小細胞肺がんにおけるPD-L1発現－腫瘍発生部位に着目した検討2018
- Author(s)
  須田健一、下治正樹、西野将矢、藤野智大、古賀教将、小原秀太、千葉眞人、武本智樹、清水重喜、光冨徹哉
- Organizer
  第59回日本肺癌学会総会
- Data Source
  KAKENHI-PROJECT-18K07336
[Presentation] Compound mutations: focusing on EGFR-mutated lung cancers2018
- Author(s)
  Kenichi Suda
- Organizer
  77th Annual Meeting of the Japanese Cancer Association
- Invited
- Data Source
  KAKENHI-PROJECT-18K07336
[Presentation] Qualitative and quantitative heterogeneity in acquiring resistance to EGFR kinase inhibitors in lung cancer2015
- Author(s)
  Suda K., MUrakami I., Sakai K., et al.
- Organizer
  WCLC 2015
- Place of Presentation
  Colorado Convention Center (CO, USA)
- Year and Date
  2015-09-09
- Data Source
  KAKENHI-PROJECT-15K18450
[Presentation] 要望演題4: 肺腺がんにおける遺伝子異常とその病理形態学的特徴2015
- Author(s)
  須田健一、　佐藤克明、　清水重喜、　他
- Organizer
  第32回日本呼吸器外科学会総会
- Place of Presentation
  サンポートホール高松（香川県）
- Year and Date
  2015-05-15
- Data Source
  KAKENHI-PROJECT-15K18450
[Presentation] IASLC/ATS/ERS新国際分類に基づく肺腺癌組織亜型における遺伝子変異の探索的検討2015
- Author(s)
  須田健一、　佐藤克明、　清水重喜、　他
- Organizer
  第115回日本外科学会定期学術集会
- Place of Presentation
  名古屋国際会議場（愛知県）
- Year and Date
  2015-04-18
- Data Source
  KAKENHI-PROJECT-15K18450
[Presentation] EGFR野生型肺癌におけるエルロチニブ獲得耐性機序の探索2014
- Author(s)
  須田健一、水内寛、佐藤克明、武本智樹、岩崎拓也、南憲司、光冨徹哉
- Organizer
  第114回日本外科学会定期学術集会
- Place of Presentation
  京都
- Data Source
  KAKENHI-PROJECT-25830119
[Presentation] In vitro analysis of acquired resistance mechanisms to EGFR tyrosine kinase inhibitors in lung cancer2014
- Author(s)
  Suda K, Mizuuchi H, Sato K, Takemoto T, Iwasaki T, Minami K, Mitsudomi T
- Organizer
  2nd International Symposium of Training Plan for Oncology Professionals
- Place of Presentation
  Osaka
- Invited
- Data Source
  KAKENHI-PROJECT-25830119
[Presentation] Several receptor tyrosine kinase is activated but orchestrated by EGFR in EGFR-TKI acquired resistant lung adenocarcinoma cells with EGFR mutation2013
- Author(s)
  Suda K, Mizuuchi H, Sato K, Takemoto T, Iwasaki T, Minami K, Yatabe Y, Mitsudomi T
- Organizer
  15th World Conference on Lung Cancer
- Place of Presentation
  Sydney
- Data Source
  KAKENHI-PROJECT-25830119
[Presentation] Prognostic And Predictive Implication Of Epidermal Growth Factor Receptor Gene Mutation On Overall Survival In Non-Small Cell Lung Cancer Patients With Postsurgical Recurrence2013
- Author(s)
  Suda K.
- Organizer
  Academic Surgical Congress 2013
- Place of Presentation
  New Orleans
- Data Source
  KAKENHI-PROJECT-24890159
[Presentation] 臨床検体より樹立したゲフィチニブ獲得耐性細胞株の解析2013
- Author(s)
  須田健一、伊藤志門、水内寛、武本智樹、岩崎拓也、南憲司、谷田部恭、光冨徹哉
- Organizer
  第54回日本肺癌学会総会
- Place of Presentation
  東京
- Data Source
  KAKENHI-PROJECT-25830119
[Presentation] In vitro acquired resistance model to EGFR-TKIs in EGFR mutated lung cancer
- Author(s)
  Suda K.
- Organizer
  第71回日本癌学会総会
- Place of Presentation
  札幌
- Data Source
  KAKENHI-PROJECT-24890159
[Presentation] Molecular and pathological evolution in acquisition of resistance to EGFR-TKI - T790M mutation and SCLC transformation-
- Author(s)
  Kenichi Suda, Isao Murakami, Katsuaki Sato, Shuta Tomida, Hiroshi Mizuuchi, Kazuko Sakai, Shigeki Shimizu, Kenji Tomizawa, Toshiki Takemoto, Masahiro Sakaguchi, Kazuto Nishio, Yasushi Yatabe, and Tetsuya Mitsudomi
- Organizer
  第73回日本癌学会学術総会
- Place of Presentation
  横浜（パシフィコ横浜）
- Year and Date
  2014-09-25 – 2014-09-27
- Data Source
  KAKENHI-PROJECT-25830119
[Presentation] Reciprocal relationship between EGFR T790M mutation and small cell lung cancer transformation as acquired resistance molecular mechanisms to EGFR kinase inhibitor
- Author(s)
  Kenichi Suda, Katsuaki Sato, Isao Murakami, Hiroshi Mizuuchi, Kazuko Sakai, Shuta Tomida, Shigeki Shimizu, Yoshihisa Kobayashi, Masaki Shimoji, Kenji Tomizawa, Toshiki Takemoto, Takuya Iwasaki, Masahiro Sakaguchi, Kazuto Nishio, Yasushi Yatabe, and Tetsuya Mitsudomi
- Organizer
  6th Asia Pacific Lung Cancer Conference
- Place of Presentation
  Kuala Lumpur（Shangri-La Hotel）
- Year and Date
  2014-11-06 – 2014-11-08
- Data Source
  KAKENHI-PROJECT-25830119
[Presentation] CRKL gene amplification in acquired resistant lung cancers with epidermal growth factor receptor mutation to tyrosine kinase inhibitors - analysis of in vitro models and clinical specimens
- Author(s)
  Suda K.
- Organizer
  5th Asia Pacific Lung Cancer Conference
- Place of Presentation
  Fukuoka
- Data Source
  KAKENHI-PROJECT-24890159
[Presentation] 肺腺癌新国際分類からみたリンパ節転移巣の再評価とその臨床的意義
- Author(s)
  須田健一、　佐藤克明、　清水重喜、　水内寛、　小林祥久、　下治正樹、　富沢健二、　武本智樹、　岩崎拓也、　阪口全宏、　光冨徹哉
- Organizer
  第67回日本胸部外科学会定期学術集会
- Place of Presentation
  福岡（福岡国際会議場、福岡サンパレスホテル＆ホール）
- Year and Date
  2014-09-30 – 2014-10-03
- Data Source
  KAKENHI-PROJECT-25830119
[Presentation] 肺腺癌新国際分類によるリンパ節転移巣の再評価とその臨床的意義
- Author(s)
  須田健一、　佐藤克明、　清水重喜、　水内寛、　小林祥久、　下治正樹、　富沢健二、　武本智樹、　岩崎拓也、　阪口全宏、　光冨徹哉
- Organizer
  第55回日本肺癌学会学術集会
- Place of Presentation
  京都（国立京都国際会館）
- Year and Date
  2014-11-14 – 2014-11-16
- Data Source
  KAKENHI-PROJECT-25830119
[Presentation] EGFR野生型肺癌におけるエルロチニブ獲得耐性機序の探索
- Author(s)
  須田健一、　水内寛、　佐藤克明、　武本智樹、　岩崎拓也、　南憲司、　阪口全宏、　光冨徹哉
- Organizer
  第114回日本外科学会定期学術集会
- Place of Presentation
  京都（国立京都国際会館、グランドプリンスホテル京都）
- Year and Date
  2014-04-03 – 2014-04-05
- Data Source
  KAKENHI-PROJECT-25830119
[Presentation] 肺癌術後再発患者におけるEGFR遺伝子変異の全生存における意義　－予後因子と予測因子－
- Author(s)
  須田　健一
- Organizer
  第50回日本癌治療学会総会
- Place of Presentation
  横浜
- Data Source
  KAKENHI-PROJECT-24890159

1. Soh Junichi (90559890)

# of Collaborated Projects: 3 results

# of Collaborated Products: 2 results
2. 光冨徹哉 (70209807)

# of Collaborated Projects: 2 results

# of Collaborated Products: 2 results
3. 津谷康大 (10534985)

# of Collaborated Projects: 2 results

# of Collaborated Products: 0 results
4. 小原秀太 (20813926)

# of Collaborated Projects: 2 results

# of Collaborated Products: 0 results
5. 冨田秀太 (10372111)

# of Collaborated Projects: 1 results

# of Collaborated Products: 2 results
6. 豊岡伸一 (30397880)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
7. 山本寛斉 (40467733)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
8. 阪口政清 (70379840)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
9. 諏澤憲 (90839713)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
10. 坂井和子 (20580559)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
11. 西尾和人 (10208134)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
12. 濱田顕 (80772954)

# of Collaborated Projects: 1 results

# of Collaborated Products: 1 results
13. MIZUUCHI Hiroshi

# of Collaborated Projects: 1 results

# of Collaborated Products: 12 results
14. SATO Katsuaki

# of Collaborated Projects: 1 results

# of Collaborated Products: 12 results

Suda Kenichi 須田 健一

SUDA Kenichi 須田 健一

Research Projects

Research Products

Co-Researchers

Evaluation of minimal residual disease in postoperative lung cancer using platelet RNA influenced by the tumor environment.

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Basic Research for Elucidating and Overcoming the Mechanisms of Progression of Early-Stage Lung Adenocarcinoma

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

EGFR変異肺癌に対する第4世代EGFR-TKIの有用性とその獲得耐性機序の解明Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Targeted therapy for the patient with KRAS mutant lung cancer

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Development of a new treatment strategy for HER2-alterated lung cancer

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Exploration of predictive molecular biomarkers for acquired resistance mechanisms to EGFR tyrosine kinase inhibitorsPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

肺癌における薬剤耐性因子のheterogenietyとその克服Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Analysis of acquired resistance mechanisms to next-generation kinase inhibitors in lung cancers with EGFR mutation.Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

EGFR変異肺癌のキナーゼ阻害剤耐性機序の解明とその克服に向けた新規治療への展開Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Book] PTEN - Structure, Mechanisms-of-Action, Role in Cell Signaling and Regulation2013

Author(s)

Total Pages

Publisher

Data Source

[Journal Article] Secondary Mutations of the EGFR Gene That Confer Resistance to Mobocertinib in EGFR Exon 20 Insertion2024

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Recent Advances in Perioperative Immunotherapies in Lung Cancer2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Prognostic role of preoperative fluorine-18 fluorodeoxyglucose-positron emission tomography/computed tomography with an image-based harmonization technique: A multicenter retrospective study2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Performance of Ultra-Rapid Idylla EGFR Mutation Test in Non-Small-Cell Lung Cancer and Its Potential at Clinical Molecular Screening2023

Suda Kenichi 須田健一

SUDA Kenichi 須田健一